Personalised blood tests which could track whether cancer treatment is working or if the disease has come back have been developed by US researchers.
The test identifies tumour DNA “rearrangements” which are specific to the individual patient.
In the future, this “genetic fingerprint” could be used to pick out tiny remnants of a tumour, Science Translational Medicine reports.
